Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042003
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2002-07-19
Brief Title:
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate Gleevec
Sponsor:
Astex Pharmaceuticals Inc
Organization:
Astex Pharmaceuticals Inc